Use of topical brimonidine to prevent intraocular pressure elevations following Nd: YAG-laser posterior capsulotomy
Deepika Singhal1★, Roopali Desai1, Sejal Desai1, Manisha Shastri1, Deepak Saxena1★ Corresponding author
- 1Department of Ophthalmology, Surat Municipal Institute of Medical Education and Research, Surat, Indian Institute of Public Health, Gandhinagar, India Research Paper.
CORRESPONDENCE
Deepika Singhal
Department of Ophthalmology, Surat Municipal Institute of Medical Education and Research, Surat, Indian Institute of Public Health, Gandhinagar, India Research Paper.
Volume 2, Issue 2 · pp. 104–106 · PUBLISHED 2011 · DOI: 10.4103/0976-500X.81902
View on J Pharmacol. Pharmacother. original site ↗
ABSTRACT
Objective: To study the effect of brimonidine on intraocular pressure (IOP) following capsulotomy among Indian subjects. Materials and Methods: The study was a nonrandomized trial with open label. Results: 80% of the subjects showed a decrease in IOP after instilling 0.2% brimonidine (1 hour pre capsulotomy). No such decrease was observed in control. After 1 and 4 h post capsulotomy a statistically signifi cant decrease in IOP ranging between 1–10 mmHg was found in 73.3% of the treatment group. Conclusions: In the present study 0.2% brimonidine has been proven effective to counteract the increase in IOP following Nd-YAG laser capsulotomy in Indian setting.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Singhal, D., Desai, R., Desai, S., Shastri, M., & Saxena, D. (2011). Use of topical brimonidine to prevent intraocular pressure elevations following Nd: YAG-laser posterior capsulotomy. Journal of Pharmacology and Pharmacotherapeutics, 2(2), 104–106. https://doi.org/10.4103/0976-500X.81902
